Compositions and methods for inhibiting hiv-1 reverse transcriptase
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsSamuel H. Wilson, William A. Beard, David D. Shock
Life of this patent
Estimating the term…
Abstract
The description provides compositions and methods of using a pyrophosphate analog, in which the bridging oxygen is replaced with an imido group (PNP) to increase the rate of the reverse polymerase reaction.
Claims16
A composition comprising a pyrophosphate (PPi) analog and a pharmaceutically acceptable carrier.
A method of treating or ameliorating the symptoms of a disease or disorder comprising administering to a patient in need thereof, an effective amount of a composition comprising a pyrophosphate (PPi) analog, wherein the composition is effective in treating or ameliorating at least one symptom of the disease or disorder.
A method of inhibiting the DNA synthesis reaction of HIV-1 Reverse Transcriptase in a patient comprising administering to a patient in need thereof, an effective amount of a composition comprising a pyrophosphate (PPi) analog, wherein the composition is effective in inhibiting the DNA synthesis reaction of HIV-1 Reverse Transcriptase (RT).
Dependencies are inferred from the claim text.